Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Paul Sagan currently holds 2,080 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Sagan has been a net seller of MRNA stock. They have purchased $2.1M and sold $111.4M worth of shares.
Paul Sagan's most recent insider trade was on Jun 18, 2026, when they sold 2,080 shares at $0.00 per share.
Paul Sagan serves as Executive at Moderna, Inc. (MRNA). They have executed 291 insider transactions totaling $113.5M over their tenure at the company.
Paul Sagan holds the position of Executive at Moderna, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Paul Sagan has shown a selling trading pattern, with $2.1M in total purchases and $111.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Paul Sagan was on Nov 9, 2018, when they sold $3.9M worth of AKAM shares. This transaction involved 55,500 shares at $70.46 per share.
Paul Sagan currently owns 2,080 shares of Moderna, Inc. (MRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Paul Sagan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Paul Sagan has 291 Form 4 filings on record as an insider at Moderna, Inc..
Set alerts for Paul Sagan and 40,000+ other insiders.